Ep. 62: Joe Fahmy: Why Biotech Stocks Are Emerging As Leaders In Stock Market Recovery
Investing With IBD
00:00
AYX Guided Lower in Most Recent Earnings
AYX has been doing quite well and kind of sneaking under the radar. Big data, artificial intelligence, great subscription model that they have. There are some sharp funds behind this. I think it's coming out of this sort of big double bottom on the weekly. And like we said, after big moves, they consolidate.
Transcript
Play full episode
